Final results of a multi-center, double-blind, randomized, placebo-controlled phase II study to assess the efficacy of MAGE-A3 immunotherapeutic as adjuvant therapy in stage IB/II non-small cell lung ...
In a trial, selected patients with early non-small cell lung cancer did not benefit from mediastinal lymph node dissection (LND). Mediastinal LND resulted in longer surgeries, increased bleeding, and ...
Evaluation of the hilar and mediastinal lymph nodes is part of the surgical treatment of non-small cell lung cancer (NSCLC). It is also vital to the staging of lung cancer, which determines the need ...
Theoretically, the introduction of gas as a contrast material into the various soft-tissue planes of the mediastinum, pneumomediastinography, should be the ideal radiologic technic for outlining ...
Treatment for early-stage non-small cell lung cancer is primarily surgical, but the optimal extent of resection of mediastinal lymph nodes is unclear. A 2010 Cochrane review suggested that complete ...
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study We conducted a multicenter, open-label, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback